Empagliflozin vs Midazolam

Empagliflozin vs Midazolam: Overview

This comparison examines the pharmacological differences between Empagliflozin and Midazolam.

Mechanism of Action

Empagliflozin: Selective SGLT2 inhibitor reducing renal glucose reabsorption.

Midazolam: Ultra-short-acting benzodiazepine GABA-A receptor positive allosteric modulator.

Pharmacokinetics

Half-life: Empagliflozin — 12.4 hours; Midazolam — 1.5-2.5 hours.

Chemical Properties

Molecular Formula: Empagliflozin — C23H27ClO7; Midazolam — C18H13ClFN3.

Molecular Weight: Empagliflozin — 450.9100 g/mol; Midazolam — 325.7670 g/mol.

Type: Empagliflozin — Small molecule; Midazolam — Small molecule.